227 related articles for article (PubMed ID: 31945078)
41. iDTI-ESBoost: Identification of Drug Target Interaction Using Evolutionary and Structural Features with Boosting.
Rayhan F; Ahmed S; Shatabda S; Farid DM; Mousavian Z; Dehzangi A; Rahman MS
Sci Rep; 2017 Dec; 7(1):17731. PubMed ID: 29255285
[TBL] [Abstract][Full Text] [Related]
42. Advancing drug-target interaction prediction: a comprehensive graph-based approach integrating knowledge graph embedding and ProtBert pretraining.
Djeddi WE; Hermi K; Ben Yahia S; Diallo G
BMC Bioinformatics; 2023 Dec; 24(1):488. PubMed ID: 38114937
[TBL] [Abstract][Full Text] [Related]
43. Drug-target interaction prediction using semi-bipartite graph model and deep learning.
Eslami Manoochehri H; Nourani M
BMC Bioinformatics; 2020 Jul; 21(Suppl 4):248. PubMed ID: 32631230
[TBL] [Abstract][Full Text] [Related]
44. Open-source chemogenomic data-driven algorithms for predicting drug-target interactions.
Hao M; Bryant SH; Wang Y
Brief Bioinform; 2019 Jul; 20(4):1465-1474. PubMed ID: 29420684
[TBL] [Abstract][Full Text] [Related]
45. Mutual-DTI: A mutual interaction feature-based neural network for drug-target protein interaction prediction.
Wen J; Gan H; Yang Z; Zhou R; Zhao J; Ye Z
Math Biosci Eng; 2023 Apr; 20(6):10610-10625. PubMed ID: 37322951
[TBL] [Abstract][Full Text] [Related]
46. ALDPI: adaptively learning importance of multi-scale topologies and multi-modality similarities for drug-protein interaction prediction.
Hu K; Cui H; Zhang T; Sun C; Xuan P
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35108362
[TBL] [Abstract][Full Text] [Related]
47. DTI-Voodoo: machine learning over interaction networks and ontology-based background knowledge predicts drug-target interactions.
Hinnerichs T; Hoehndorf R
Bioinformatics; 2021 Dec; 37(24):4835-4843. PubMed ID: 34320178
[TBL] [Abstract][Full Text] [Related]
48. Drug target predictions based on heterogeneous graph inference.
Wang W; Yang S; Li J
Pac Symp Biocomput; 2013; ():53-64. PubMed ID: 23424111
[TBL] [Abstract][Full Text] [Related]
49. MSI-DTI: predicting drug-target interaction based on multi-source information and multi-head self-attention.
Zhao W; Yu Y; Liu G; Liang Y; Xu D; Feng X; Guan R
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38762789
[TBL] [Abstract][Full Text] [Related]
50. BE-DTI': Ensemble framework for drug target interaction prediction using dimensionality reduction and active learning.
Sharma A; Rani R
Comput Methods Programs Biomed; 2018 Oct; 165():151-162. PubMed ID: 30337070
[TBL] [Abstract][Full Text] [Related]
51. MolTrans: Molecular Interaction Transformer for drug-target interaction prediction.
Huang K; Xiao C; Glass LM; Sun J
Bioinformatics; 2021 May; 37(6):830-836. PubMed ID: 33070179
[TBL] [Abstract][Full Text] [Related]
52. Drug-target interaction predictions with multi-view similarity network fusion strategy and deep interactive attention mechanism.
Song W; Xu L; Han C; Tian Z; Zou Q
Bioinformatics; 2024 Jun; 40(6):. PubMed ID: 38837345
[TBL] [Abstract][Full Text] [Related]
53. Prediction of drug-target interaction by label propagation with mutual interaction information derived from heterogeneous network.
Yan XY; Zhang SW; Zhang SY
Mol Biosyst; 2016 Feb; 12(2):520-31. PubMed ID: 26675534
[TBL] [Abstract][Full Text] [Related]
54. IMCHGAN: Inductive Matrix Completion With Heterogeneous Graph Attention Networks for Drug-Target Interactions Prediction.
Li J; Wang J; Lv H; Zhang Z; Wang Z
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):655-665. PubMed ID: 34115592
[TBL] [Abstract][Full Text] [Related]
55. TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models.
Yao ZJ; Dong J; Che YJ; Zhu MF; Wen M; Wang NN; Wang S; Lu AP; Cao DS
J Comput Aided Mol Des; 2016 May; 30(5):413-24. PubMed ID: 27167132
[TBL] [Abstract][Full Text] [Related]
56. Predicting Drug-Target Interactions Based on Small Positive Samples.
Hu P; Chan KCC; Hu Y
Curr Protein Pept Sci; 2018; 19(5):479-487. PubMed ID: 27829343
[TBL] [Abstract][Full Text] [Related]
57. Identifying drug-target interactions via heterogeneous graph attention networks combined with cross-modal similarities.
Jiang L; Sun J; Wang Y; Ning Q; Luo N; Yin M
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35224614
[TBL] [Abstract][Full Text] [Related]
58. Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile.
van Laarhoven T; Marchiori E
PLoS One; 2013; 8(6):e66952. PubMed ID: 23840562
[TBL] [Abstract][Full Text] [Related]
59. Bridging-BPs: a novel approach to predict potential drug-target interactions based on a bridging heterogeneous graph and BPs2vec.
Li G; Zhang P; Sun W; Ren C; Wang L
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35037024
[TBL] [Abstract][Full Text] [Related]
60. DTI-CDF: a cascade deep forest model towards the prediction of drug-target interactions based on hybrid features.
Chu Y; Kaushik AC; Wang X; Wang W; Zhang Y; Shan X; Salahub DR; Xiong Y; Wei DQ
Brief Bioinform; 2021 Jan; 22(1):451-462. PubMed ID: 31885041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
